vTv Therapeutics (VTVT) Operating Leases (2019 - 2025)
vTv Therapeutics (VTVT) reported Operating Leases of $125000.0 for Q1 2025, down 58.05% on a YoY basis from $298000.0 in Q1 2024, and up 290.62% sequentially from $32000.0 in Q3 2024.
vTv Therapeutics (VTVT) Operating Leases (2019 - 2025) Analysis & Trends
vTv Therapeutics (VTVT) has 7 years of Operating Leases data on file, last reported at $125000.0 in Q1 2025.
- For the quarter ending Q1 2025, Operating Leases fell 58.05% year-over-year to $125000.0; the trailing twelve-month figure through Mar 2025 stood at $125000.0 (down 58.05% YoY), and the FY2023 full-year result was $169000.0, down 50.0% from the prior year.
- Operating Leases advanced to $125000.0 in Q1 2025, from $32000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $633000.0 in Q1 2021 to a low of $32000.0 in Q3 2024.
- A 5-year average of $348812.5 and a median of $335500.0 in 2022 frame the typical range for Operating Leases.
- Peak annual rise in Operating Leases reached 0.34% in 2024, while the deepest fall reached 84.98% in 2024.
- Tracing VTVT's Operating Leases over 5 years: stood at $492000.0 in 2021, then tumbled by 31.3% to $338000.0 in 2022, then tumbled by 50.0% to $169000.0 in 2023, then sank by 81.07% to $32000.0 in 2024, then jumped by 290.62% to $125000.0 in 2025.
- Business Quant data shows VTVT's Operating Leases at $125000.0 in Q1 2025, $32000.0 in Q3 2024, and $79000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 125,000.00 |
| Sep 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Mar 31, 2024 | 298,000.00 |
| Dec 31, 2023 | 169,000.00 |
| Sep 30, 2023 | 213,000.00 |
| Jun 30, 2023 | 417,000.00 |
| Mar 31, 2023 | 297,000.00 |
| Dec 31, 2022 | 338,000.00 |
| Sep 30, 2022 | 333,000.00 |
| Jun 30, 2022 | 587,000.00 |
| Mar 31, 2022 | 441,000.00 |
| Dec 31, 2021 | 492,000.00 |
| Sep 30, 2021 | 540,000.00 |
| Jun 30, 2021 | 587,000.00 |
| Mar 31, 2021 | 633,000.00 |
| Dec 31, 2020 | 676,000.00 |
| Sep 30, 2020 | 717,000.00 |
| Jun 30, 2020 | 756,000.00 |
| Mar 31, 2020 | 795,000.00 |